Clinical Trial Update: KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children [Phase 3]

View source ↗

Summary

Phase 3 trial comparing KPI-121 1% to prednisolone for ocular inflammation after pediatric cataract surgery was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation

Drugs mentioned

• KPI-121 1%
• Prednisolone (Prednisolone)

Snippet

Sponsor: Kala Pharmaceuticals, Inc. | Conditions: Ocular Inflammation | Phase 3 | Status: TERMINATED | Results posted: 2020-04-07